🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Gaucher Disease, Type 3

PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) NCT04532047Phase 11 site📍 San Francisco University of California, San Francisco · Tests: Aldurazyme (laronidase) Registry of Patients Diagnosed With Lysosomal Storage Diseases NCT05619900n/a1 site📍 San Francisco University of California, San Francisco · Tests: There is no intervention A Gaucher Disease Gene Therapy Trial With FLT201 NCT07223944Phase 332 sites📍 Los Angeles📍 Los Angeles📍 San Francisco Spur Therapeutics · Tests: FLT201 Gaucherite - A Study to Stratify Gaucher Disease NCT03240653n/a8 sites📍 Birmingham📍 Birmingham📍 Cambridge Cambridge University Hospitals NHS Foundation Trust · Tests: Stratified response to Enzyme Therapy MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3) NCT05586243n/a1 site📍 Minneapolis University of Minnesota · Tests: No intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy